Canada markets closed

Checkpoint Therapeutics Inc (CZTA.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
1.7420+0.0220 (+1.28%)
At close: 09:53PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
134
103
192
268
1,069
-
Operating Expenses
Research Development
63,247
43,566
49,825
48,453
16,352
-
Selling General and Administrative
8,346
8,685
8,700
8,538
7,918
-
Total Operating Expenses
71,593
52,251
58,525
56,991
24,270
-
Operating Income or Loss
-71,459
-52,148
-58,333
-56,723
-23,201
-
Total Other Income/Expenses Net
-7,350
217
-4,451
-
-
-
Income Before Tax
-71,358
-51,847
-62,624
-56,670
-23,081
-
Income from Continuing Operations
-71,358
-51,847
-62,624
-56,670
-23,081
-
Net Income
-71,358
-51,847
-62,624
-56,670
-23,081
-
Net Income available to common shareholders
-71,358
-51,847
-62,624
-56,670
-23,081
-
Basic EPS
-4.38
-
-7.09
-7.45
-4.10
-7.00
Diluted EPS
-4.38
-
-7.09
-7.45
-4.10
-7.00
Basic Average Shares
14,188
-
8,836
7,603
5,583
3,530
Diluted Average Shares
14,188
-
8,836
7,603
5,583
3,530